168
Participants
Start Date
July 31, 2012
Primary Completion Date
February 28, 2014
Study Completion Date
April 30, 2014
Nexagon® Low Dose
Twice weekly, topical application of Nexagon® low dose in addition to a Removable Cast Walker
Nexagon® Medium Dose
Twice weekly, topical application of Nexagon® medium dose in addition to a Removable Cast Walker
Nexagon® High Dose
Twice weekly, topical application of Nexagon® high dose in addition to a Removable Cast Walker
Nexagon® vehicle
Twice weekly, topical application of Nexagon® vehicle in addition to a Removable Cast Walker
Cherkasy Regional Clinical Hospital, Endocrinology Department, Cherkasy
Barry University Clinical Research, Hialeah
Univeristy of Miami, Miller School of Medicine, Dermatology Research, Miami
Doctors Research Network, South Miami
Dnipropetrovsk Regional Clinical Hospitaln. a. I.I. Mechnikov, Dnipropetrovsk
Regional Clinical Hospital, Cardiovascular Surgery Department, Kharkiv
Zaporizhzhya City Clinical Hospital #9, Zaporizhzhya
Ivano-Frankivsk Central City Clinical Hospital, Ivano-Frankivsk
Houston Foot and Ankle Care, Houston
Associated Foot and Ankle Specialists, LLC, Phoenix
University of Arizona Medical Center, Tucson
Advanced Foot and Ankle Center, Las Vegas
Advanced Foot Care and Clinical Research Center, Fresno
Center For Clinical Research Inc., Castro Valley
Endocrinology Science Center, Moscow
Endocrinology Clinic of Moscow, Department of Healthcare, Moscow
Moscow Medical University n.a., Moscow
Federal bureau of medical and social expertise, Moscow, Moscow
St Petersburg City Hospital of St Elizabeth, Saint Petersburg
St Petersburg Diagnostic Center, Saint Petersburg
Kemerovo Regional Clinical Hospital, Kemerovo
City Clinical Hospital #13, Moscow
Voronezh Regional Clinical Consultative Diagnostic Center, Voronezh
Kyiv City Clinical Hospital #1, Kyiv
Institute of Endocrinology and Methabolism n.a. V.P. Komisarenko, Clinical Diabetology Department, Kyiv
Lead Sponsor
OcuNexus Therapeutics, Inc.
INDUSTRY